Advanced Pharmaceutical ConsulataNTS, iNC. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Advanced Pharmaceutical ConsulataNTS, iNC.

Sort by

Viewing results 1‒25 of 438

Covid-19 vaccines
EU delays approval of Novavax’s revised Covid jab
...Novavax “intends to supply doses of our vaccine to European countries that have requested it through advanced purchase agreement post-authorisation”, it said....
October 15, 2023
HTSI
Exploring beauty’s biotech frontier
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
October 24, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Tidjane Thiam
Tidjane Thiam’s Spac in merger talks with life sciences group Human Longevity
...Pimco has soured on the Spac market after being involved in a bad deal as co-sponsor of Capstar Partners, which merged with pharmaceuticals company Gelesis last year....
June 20, 2022
Novavax Inc
Cash-strapped Novavax urges governments to honour Covid jab deals
...Jacobs said Novavax expected to deliver on the $800mn advanced purchase agreements with the EU, Australia, Canada and New Zealand, which are due for delivery this year....
May 14, 2023
Japanese business & finance
Japan’s Astellas to buy US biotech group Iveric Bio for $5.9bn
...The company’s development of new drugs has not advanced as quickly as it forecast....
May 1, 2023
InterviewJapanese business & finance
Japanese pharma boss rules out China exit after executive’s arrest
...In his first public comments since its employee was arrested in late March on espionage charges, Naoki Okamura said Japan’s second-largest pharmaceutical company by revenue planned to take further steps...
April 9, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Dementia
Two Alzheimer’s drugs offer hope to patients after decades of waiting
...But none of these are as advanced as lecanemab and donanemab....
May 8, 2023
LexDrugs research
Medicines: triumph of science in 2022 is worth celebrating Premium content
...AstraZeneca’s Lynparza, which is used for multiple tumour types, has just won EU approval for advanced prostate cancer. The group scored another notable success with Enhertu....
December 23, 2022
Mergers & Acquisitions
Pfizer in talks to buy Global Blood Therapeutics for roughly $5bn
...The Wall Street Journal first reported that Pfizer was in advanced talks with GBT....
August 5, 2022
InterviewNew York City
‘No big company is coming to the city’: biotech developer bemoans New York’s status
...They may have limited cash, changing needs and future business prospects that require advanced science degrees to evaluate....
July 7, 2022
HSBC Holdings PLC
HSBC to leave longtime New York headquarters for new west side tower
...Tishman Speyer, one of New York’s largest commercial property developers, had previously secured pharmaceuticals company Pfizer as its anchor tenant for the Spiral....
May 2, 2022
Covid-19 vaccines
Covid vaccine makers face investor pressure over global access
...“Pharmaceutical companies have a duty to do their utmost on this but unfortunately we see that they are lagging behind....
January 6, 2022
Coronavirus treatment
US spends $2bn to secure Covid-19 vaccine
...The US move comes after the UK government ordered 30m doses of BioNTech’s vaccine and 60m doses of another vaccine from Valneva of France, which is less advanced in clinical development....
July 22, 2020
Coronavirus treatment
Britain signs up for 90m doses of German and French vaccines
...At the same time, the UK government committed to buying 60m doses of a coronavirus vaccine from Valneva of France, which is less advanced in development but works in a different way to BioNTech’s....
July 20, 2020
Coronavirus treatment
Pfizer’s Covid antiviral pill slashes hospitalisation risk, trial shows
...Rival cruise operator Carnival advanced more than 7 per cent....
November 5, 2021
FT Live
Global Insurance Summit
Strengthening resilience, capital and innovation as systemic risks evolve
Thursday, 13 JuneLondon, UK
News in-depthNikkei Asia
The resilience myth: fatal flaws in the push to secure chip supply chains
...A version of this article was first published by Nikkei Asia on July 27. ©2022 Nikkei Inc. All rights reserved....
August 4, 2022
Japanese politics & policy
Japan depends on overseas vaccines due to 30 years of inaction
...A version of this article was first published by Nikkei Asia on May 10 2021. ©2021 Nikkei Inc. All rights reserved....
May 17, 2021
The Big Read
The Alzheimer’s economy: is the new $56,000-a-year drug worth it?
...Sanjiv Sharma, Borghoff’s doctor and founder of the Advanced Memory Institute of New Jersey, acknowledges the obstacles that lie ahead if it is to reach all those who could potentially benefit....
June 11, 2021
Covid-19 vaccines
The next generation Covid-19 vaccines seeking a slice of the market
...“When you make a product essentially everyone in the world wants or needs, you are going to make a lot of money,” said Walid Gellad, director of the centre for pharmaceutical policy and prescribing at the...
June 11, 2021
Covid-19 vaccines
Biden says US will have enough jabs to vaccinate all adults by end of May
...Merck will manufacture doses of Johnson & Johnson’s Covid-19 vaccine after receiving $269m from the US Biomedical Advanced Research and Development Authority to adapt its manufacturing facilities to produce...
March 2, 2021
Covid-19 vaccines
Covid vaccines show few serious side-effects after millions of jabs
...Despite concerns about possible side-effects as Covid-19 vaccines are rolled out around the world, evidence from the UK’s well-advanced vaccination programme suggests recipients of the leading jabs have...
March 2, 2021
FT CollectionsGreensill Capital
Australia’s IAG denies exposure to Greensill after share plunge
...Credit Suisse has appointed McGrathNichol as receiver to a Greensill company in Australia in a bid to secure its interests, including a $140m loan advanced to the finance firm last year....
March 9, 2021
News in-depthFT Film24 min
Covid-19 and the business of vaccines
...It was made by US pharmaceutical giant Pfizer and Germany's BioNTech....
March 10, 2021
The FT ViewThe editorial board
A first glimmer of hope for a Covid vaccine
...Fortunately for advanced economies, the US, UK, EU, Japan and others have already pre-ordered large numbers of doses of the Pfizer vaccine....
November 9, 2020
Coronavirus treatment
EU to buy up to 300m doses of BioNTech-Pfizer’s Covid vaccine
...The Swiss government confirmed to the Financial Times that its negotiations with BioNTech and Pfizer “are at an advanced stage”....
November 11, 2020

Previous pagePage 1 of 18Next page